Role of CD11B/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 850-859

  Eby, Joshua C ^a   Gray, Mary C ^a   Mangan, Annabelle R ^a,b   Donato, Gina M ^a   Hewlett, Erik L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE TOXIN; CD11B ANTIGEN; CD18 ANTIGEN; CYCLIC AMP; TRYPSIN;

ANIMAL CELL; ARTICLE; BORDETELLA PERTUSSIS; CELL MEMBRANE; CELL STRAIN K 562; CELL SURFACE; CHO CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; IN VITRO STUDY; INTOXICATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ADENYLATE CYCLASE TOXIN; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD18; BORDETELLA PERTUSSIS; CHO CELLS; CRICETINAE; CYCLIC AMP; MACROPHAGE-1 ANTIGEN; PROTEIN STRUCTURE, TERTIARY;

EID: 84857060003     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05979-11     Document Type: Article

References (59)

1. Bachelet M, Richard MJ, Francois D, Polla BS. 2002. Mitochondrial alterations precede Bordetella pertussis-induced apoptosis. FEMS Immunol. Med. Microbiol. 32:125-131.
2. Barry EM, et al. 1991. Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J. Bacteriol. 173:720-726.
3. Basler M, et al. 2007. Segments crucial for membrane translocation and pore-forming activity of Bordetella adenylate cyclase toxin. J. Biol. Chem. 282:12419-12429.
4. Basler M, Masin H, Osicka R, Sebo P. 2006. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect. Immun. 74:2207-2214.
5. Benz R, Maier E, Ladant D, Ullmann A, Sebo P. 1994. Adenylate-cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J. Biol. Chem. 269:27231-27239.
6. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
7. Bumba L, Masin J, Fiser R, Sebo P. 2010. Bordetella adenylate cyclase toxin mobilizes its beta(2) integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps. PLoS Pathog. 6:e1000901.
8. Confer DL, Eaton JW. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948-950.
9. Dong HL, Osmanova V, Epstein PM, Brocke S. 2006. Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes. Biochem. Biophys. Res. Commun. 345:713-719.
10. Dunne A, et al. 2010. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunology 185:1711-1719.
11. Eby JC, et al. 2010. Selective translocation of the Bordetella pertussis adenylate cyclase toxin across the basolateral membranes of polarized epithelial cells. J. Biol. Chem. 285:10662-10670.
12. Eidels L, Proia RL, Hart DA. 1983. Membrane receptors for bacterial toxins. Microbiol. Rev. 47:596-620.
13. El-Azami-El-Idrissi M, et al. 2003. Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: role of toxin acylation and identification of the main integrin interaction domain. J. Biol. Chem. 278:38514-38521.
14. Fiser R, et al. 2007. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b + monocytes independently of the catalytic and hemolytic activities. J. Biol. Chem. 282:2808-2820.
15. Friedman E, Farfel Z, Hanski E. 1987. The invasive adenylate cyclase of Bordetella pertussis. Properties and penetration kinetics. Biochem. J. 243: 145-151.
16. Glaser P, et al. 1988. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol. Microbiol. 2:19-30.
17. Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A. 1988. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclasehaemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:3997-4004.
18. Goldhammer AR, et al. 1981. Spurious protein activators of Bordetella pertussis adenylate cyclase. Eur. J. Biochem. 115:605-609.
19. Gordon VM, Leppla SH, Hewlett EL. 1988. Inhibitors of receptormediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 56:1066-1069.
20. Gordon VM, et al. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 264:14792-14796.
21. Gray M, Szabo G, Otero AS, Gray L, Hewlett E. 1998. Distinct mechanisms for K+ Universal-GreekwithMathPi.-1.H11001 efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J. Biol. Chem. 273:18260-18267.
22. Gray MC, Hewlett EL. 2011. Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Cell. Microbiol. 13:123-134.
23. Gray MC, et al. 2001. Translocation-specific conformation of adenylate cyclase toxin from Bordetella pertussis inhibits toxin-mediated hemolysis. J. Bacteriol. 183:5904-5910.
24. Guermonprez P, et al. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the αMβ2 MathematicalPi-One.-1.H92522 (integrin CD11b/CD18). J. Exp. Med. 193:1035-1044.
25. Guermonprez P, Ladant D, Karimova G, Ullmann A, Leclerc C. 1999. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J. Immunol. 162:1910-1916.
26. Hackett M, Guo L, Shabanowitz J, Hunt DF, Hewlett EL. 1994. Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266:433-435.
27. Hanski E, Farfel Z. 1985. Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J. Biol. Chem. 260:5526-5532.
28. Hewlett EL, Donato GM, Gray MC. 2006. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol. Microbiol. 59:447-459.
29. Hewlett EL, et al. 1993. Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene cyaC. J. Biol. Chem. 268:7842-7848.
30. Hickey FB, Brereton CF, Mills KH. 2008. Adenylate cyclase toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J. Leukoc. Biol. 84:234-243.
31. Ingalls RR, Arnaout MA, Golenbock DT. 1997. Outside-in signaling by lipopolysaccharide through a tailless integrin. J. Immunol. 159:433-438.
32. Iwaki M, Ullmann A, Sebo P. 1995. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol. Microbiol. 17:1015-1024.
33. Iwamoto R, Senoh H, Okada Y, Uchida T, Mekada E. 1991. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor. J. Biol. Chem. 266:20463-20469.
34. Kamanova J, et al. 2008. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J. Immunol. 181: 5587-5597.
35. Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL. 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 67:2090-2095.
36. Lieberthal W, Menza SA, Levine JS. 1998. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am. J. Physiol. 274(2 Pt 2):F315-F327.
37. Martin C, Gomez-Bilbao G, Ostolaza H. 2010. Bordetella adenylate cyclase toxin promotes calcium entry into both CD11b(+) and CD11b(-) cells through cAMP-dependent L-type-like calcium channels. J. Biol. Chem. 285:357-364.
38. Martin C, et al. 2004. Membrane restructuring by Bordetella pertussis adenylate cyclase toxin, a member of the RTX toxin family. J. Bacteriol. 186:3760-3765.
39. Martin C, Uribe KB, Gomez-Bilbao G, Ostolaza H. 2011. Adenylate cyclase toxin promotes internalisation of integrins and raft components and decreases macrophage adhesion capacity. PLoS One 6:e17383.
40. Masin J, Konopasek I, Svobodova J, Sebo P. 2004. Different structural requirements for adenylate cyclase toxin interactions with erythrocyte and liposome membranes. Biochim. Biophys. Acta 1660:144-154.
41. Matheson BK, Adams JL, Zou J, Patel R, Franklin RB. 2007. Effect of metabolic inhibitors on ATP and citrate content in PC3 prostate cancer cells. Prostate 67:1211-1218.
42. Middlebrook JL, Dorland RB, Leppla SH. 1978. Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J. Biol. Chem. 253:7325-7330.
43. Mitamura T, et al. 1992. The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from Vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J. Cell Biol. 118:1389-1399.
44. Naglich JG, Metherall JE, Russell DW, Eidels L. 1992. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051-1061.
45. +T-cell epitopes into major histo-compatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect. Immun. 68:247-256.
46. Osickova A, Osicka R, Maier E, Benz R, Sebo P. 1999. An amphipathic α-helix including glutamates 509 and 516 is crucial for membrane translocation of adenylate cyclase toxin and modulates formation and cation selectivity of its membrane channels. J. Biol. Chem. 274:37644-37650.
47. Paccani SR, et al. 2008. Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis. Infect. Immun. 76:2822-2832.
48. Paccani SR, et al. 2011. The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapse. J. Exp. Med. 208:1317-1330.
49. Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL. 1987. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J. Immunol. 139:2749-2754.
50. Rossi Paccani S, et al. 2009. The adenylate cyclase toxins of Bacillus Cellular Effects of Bordetella Adenylate Cyclase Toxin anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog. 5:e1000325.
51. Salomon Y, Londos C, Rodbell M. 1974. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:541-548.
52. Scobie HM, Rainey GJ, Bradley KA, Young JA. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. U. S. A. 100:5170-5174.
53. Sorensen M, Sehested M, Jensen PB. 1999. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation of cleavable-complex formation by etoposide but not by amsacrine. Mol. Pharmacol. 55:424-431.
54. Spensieri F, et al. 2006. Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect. Immun. 74:2831-2838.
55. Szabo G, Gray MC, Hewlett EL. 1994. Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J. Biol. Chem. 269: 22496-22499.
56. Terada H. 1990. Uncouplers of oxidative phosphorylation. Environ. Health Perspect. 87:213-218.
57. Vojtova J, Kofronova O, Sebo P, Benada O. 2006. Bordetella adenylate cyclase toxin induces a cascade of morphological changes of sheep erythrocytes and localizes into clusters in erythrocyte membranes. Microsc. Res. Tech. 69:119-129.
58. Vojtova-Vodolanova J, et al. 2009. Oligomerization is involved in pore formation by Bordetella adenylate cyclase toxin. FASEB J. 23:2831-2843.
59. Xiong YM, Chen J, Zhang L. 2003. Modulation of CD11b/CD18 adhesive activity by its extracellular, membrane-proximal regions. J. Immunol. 171:1042-1050.